Retiform Purpura of the Lower Limbs Associated with Levamisole-Adulterated Cocaine.
Cocaine
antiphospholipid syndrome
levamisole
retiform purpura
vasculitis
Journal
European journal of case reports in internal medicine
ISSN: 2284-2594
Titre abrégé: Eur J Case Rep Intern Med
Pays: Italy
ID NLM: 101648453
Informations de publication
Date de publication:
2022
2022
Historique:
received:
13
04
2022
accepted:
19
04
2022
entrez:
6
5
2022
pubmed:
7
5
2022
medline:
7
5
2022
Statut:
epublish
Résumé
A young man was treated in hospital for sepsis, disseminated intravascular coagulation and multi-organ failure. He was a regular intranasal cocaine user up to 1 day prior to symptom onset. Clinical examination revealed extensive retiform purpura affecting both his lower limbs. Skin biopsy revealed widespread thrombosis in the small- and medium-sized vessels of the mid dermis and the subcutaneous fat with surrounding leucocytoclasis. There was also extensive ischaemic necrosis of the upper reticular and papillary dermis and focal ischaemic necrosis of the epidermis. These findings were in keeping with a thrombotic vasculopathy with associated cutaneous ischaemic necrosis, likely associated with levamisole-adulterated cocaine (LAC). An autoimmune screen showed extremely raised levels of anti-B2-glycoprotein IgM, IgG and anti-cardiolipin IgG antibodies, usually seen in antiphospholipid syndrome (APS). The literature describes how APS could be secondary to various underlying conditions, including LAC, and that levamisole toxicity may mimic APS and hence be missed. Levamisole is a common adulterant found in cocaine; the resultant toxicity can present with cutaneous manifestations, namely retiform purpura and skin necrosis, similar to antiphospholipid syndrome.Patients presenting with such features should be asked about illicit drug use, specifically cocaine, and investigated by screening urine for drugs of abuse and serum antihuman elastase antibody when possible.
Identifiants
pubmed: 35520371
doi: 10.12890/2022_003353
pii: 3353-1-28512-1-10-20220427
pmc: PMC9067424
doi:
Types de publication
Journal Article
Langues
eng
Pagination
003353Informations de copyright
© EFIM 2022.
Déclaration de conflit d'intérêts
Conflicts of Interests: The Authors declare that there are no competing interest
Références
J Thromb Thrombolysis. 2012 Jul;34(1):7-10
pubmed: 22437653
Am J Dermatopathol. 2013 Oct;35(7):722-30
pubmed: 23392134
WMJ. ;116(1):37-9
pubmed: 29099568
Dermatol Online J. 2011 Apr 15;17(4):12
pubmed: 21549087
Rheumatology (Oxford). 2015 Aug;54(8):1533-4
pubmed: 26070938